DUPIXENT is indicated as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (CRSwNP).1

Some examples of CRSwNP patients who may be appropriate for DUPIXENT are1:

NSAID-ERD, nonsteroidal anti-inflammatory drug–exacerbated respiratory disease.

Explore patient types appropriate for DUPIXENT